DUBLIN--(BUSINESS WIRE)--The "Anatomic Pathology Market by Product & Service (Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)), End User, Region - Global Forecasts to 2025" report has been added to ResearchAndMarkets.com's offering.
The global anatomic pathology market size is projected to reach a value of USD 46.8 billion by 2025 from USD 33.3 billion in 2020, at a CAGR of 7.1% during the forecast period. The growth in this market is attributed to the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent in the coming years.
Disease diagnosis segment accounted for the larger share of the anatomic pathology market, by application, in 2019.
Based on the application, the anatomic pathology market is segmented into disease diagnosis and medical research. In 2019, the disease diagnosis segment accounted for the larger market share, due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.
Hospital laboratories to register the highest growth in the anatomic pathology market during the forecast period.
Based on end-users, the anatomic pathology market is segmented into clinical laboratories, hospital laboratories, and other end users. The hospital laboratories segment accounted for the largest market share in 2019 and is projected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing number of patient visits to hospitals, a growing number of in-house diagnostic procedures performed in hospitals, rising awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.
North America will continue to dominate the anatomic pathology market during the forecast period
Geographically, the anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Anatomic Pathology Market, by Product & Service
7 Anatomic Pathology Market, by Application
8 Anatomic Pathology Market, by End-user
9 Anatomic Pathology Market, by Region
10 Competitive Landscape
11 Company Profiles
12 Adjacent Market
- Abcam plc.
- Agilent Technologies
- Amos Scientific Pty Ltd
- Becton, Dickinson and Company
- Bio SB
- Bright Instruments
- Cell Signaling Technology
- Cellpath Ltd.
- Danaher Corporation
- Diapath S.P.A.
- F. Hoffman-La Roche Ltd.
- Histo-Line Laboratories
- Hologic, Inc.
- Jinhua Yidi Medical Appliance Co. Ltd
- Medite Medical GmbH
- Merck KGaa
- Micros Austria
- Milestone Medical
- PHC Holdings Corporation
- Sakura Finetek Usa Inc.
- Scilab Co Ltd
- SLEE Medical GmbH
For more information about this report visit https://www.researchandmarkets.com/r/o0jti4
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.